Navigation Links
University of Helsinki and ASM International renew research agreement on atomic layer deposition
Date:1/21/2009

Department of Chemistry at the University of Helsinki and ASM Microchemistry Ltd. have renewed their long-term research agreement. ASM Microchemistry Ltd. is a subsidiary of the semiconductor processing tool supplier ASM International N.V. based in the Netherlands. The new agreement is a seamless continuation to the preceding 5-year collaboration project started in 2004 and includes research funding for four PhD students. As part of this collaboration, ASM has located its research and development unit ASM Microchemistry at the campus of the Chemistry Department of the University of Helsinki. The clean room and laboratory were built and opened in 2004 and the office was moved into the campus in early 2006.

The collaboration is about Atomic Layer Deposition (ALD) which is an advanced technology for depositing thin film materials in highly controlled manner for integrated circuits and other applications. Microchemistry and University of Helsinki have been pioneering the ALD technology since 1987 and 1990, respectively. Today ASM is a leading ALD equipment and process supplier to the semiconductor industry, and the University of Helsinki is one of the world's leading academic research institutes in the field of ALD.

As Dr. Marko Tuominen, Managing Director of ASM Microchemistry put it after renewal of the agreement: - The more challenging tasks we give to the University the more successful the scientists are in their work. Also by getting the nearly impossible done greatly strengthens our position in semiconductor industry in the form of intellectual property rights.

Furthermore, Tuominen has found the cooperation and physical location close to University as perfect arrangement for a small research company. He also likes to emphasize that the basic ALD process screening done in the University greatly speeds up the development, since the non-working process options have been ruled out well in advance. This further makes it possible to concentrate more on developing the working processes and transferring these to ASM's business units.

- In the current situation of fragmented research funding, this agreement is exceptional both in terms of length and volume, comment academy professor Markku Leskel and professor Mikko Ritala, who head the ALD research group at the Laboratory of Inorganic Chemistry at the University. - We and our students also greatly appreciate this kind of collaboration with industry which takes us to the area where basic and applied research becomes mixed. The questions we are dealing with in our research are fundamental by their nature, yet their solutions may find rapid use in the future semiconductor devices.


'/>"/>

Contact: Prof. Mikko Ritala
mikko.ritala@helsinki.fi
358-091-915-0193
University of Helsinki
Source:Eurekalert

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):